<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02296775</url>
  </required_header>
  <id_info>
    <org_study_id>RI-01-003</org_study_id>
    <nct_id>NCT02296775</nct_id>
  </id_info>
  <brief_title>Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid Arthritis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Reddy's Laboratories Limited</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dr. Reddy's Laboratories Limited</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare the plasma pharmacokinetic profile and the change in disease activity
      score in patients with active rheumatoid arthritis following treatment with two 1000 mg doses
      of DRL_RI or one of two sources of rituximab (Rituxan® or MabThera®). Patients will also be
      monitored for safety, B cell depletion and recovery, and for the development of immune
      responses to the administered study drugs
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cmax</measure>
    <time_frame>Week 16</time_frame>
    <description>Maximum plasma concentration after second dose</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AUC 0-∞</measure>
    <time_frame>Week 16</time_frame>
    <description>Area under concentration-time curve extrapolated from time 0 to infinity after the second dose</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AUC 0-t</measure>
    <time_frame>Week 16</time_frame>
    <description>Area under concentration-time curve from time 0 to the time of the last quantifiable concentration after the second dose</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients achieving ACR20, ACR50 and ACR70</measure>
    <time_frame>Week 24</time_frame>
    <description>American College of Rheumatology criteria for 20% response, 50% response and 70% response</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change from baseline in DAS28-CRP</measure>
    <time_frame>Week 24</time_frame>
    <description>28-joint Disease Activity Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>B cell depletion and recovery</measure>
    <time_frame>Week 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of anti-drug antibodies</measure>
    <time_frame>Week 52</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">276</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>DRL_RI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Rituxan</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>MabThera</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>DRL_RI</intervention_name>
    <description>Two 1000 mg intravenous infusions, one each on Day 1 and Day 15</description>
    <arm_group_label>DRL_RI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Rituxan</intervention_name>
    <description>Two 1000 mg intravenous infusions, one each on Day 1 and Day 15</description>
    <arm_group_label>Rituxan</arm_group_label>
    <other_name>Rituximab</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>MabThera</intervention_name>
    <description>Two 1000 mg intravenous infusions, one each on Day 1 and Day 15</description>
    <arm_group_label>MabThera</arm_group_label>
    <other_name>Rituximab</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female patients, 18 to 65 years of age

          2. Diagnosis of RA, according to ACR criteria (1987), of at least 6 months duration

          3. At randomization, tender joint count ≥ 6 and swollen joint count ≥ 6

          4. Evidence of at least moderate disease activity

          5. Patients receiving oral or parenteral MTX with a dose of 15 to 25 mg per week when
             given alone or 10 to 25 mg per week in combination with additional non-biologic
             DMARD(s) for at least 6 months and on stable dose for at least 3 months

          6. Patients must be on a stable dose of folic acid or equivalent (≥5 mg per week)

          7. Chest X-ray not suggestive of any lung infections including pulmonary tuberculosis
             (TB)

          8. Contraception required per protocol

        Exclusion Criteria:

          1. Prior therapy with

               -  Rituximab, abatacept, tocilizumab, anakinra or an agent/antibody targeting CD20,
                  CD19 or B cells

               -  Tumor necrosis factor (TNF) alfa antagonists or other biologic DMARDs

             Other prior or concurrent therapies may also be excluded

          2. Any clinically relevant abnormality detected on screening history, physical
             examination, clinical laboratory, chest X-ray, or electrocardiogram (ECG), other than
             values consistent with RA

          3. Evidence of active, suspected or inadequately treated TB

          4. Positive serological test for hepatitis C virus antibodies, hepatitis B surface
             antigen, hepatitis B core antibody, or human immunodeficiency virus

          5. History of cardiovascular disease, history of stroke, or uncontrolled hypertension

          6. History of lymphoproliferative disease or organ allograft

          7. History of cancer (except for in situ cancer, excised, or limited stage, curatively
             treated cancer with no sign of disease for &gt;5 years)

          8. History of allergy (medication history) to any of the compounds used in the study

          9. Pregnant or lactating women or women planning to become pregnant during the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Gurunank Care Hospital</name>
      <address>
        <city>Hyderabad</city>
        <state>Andhra Pradesh</state>
        <zip>500020</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jugal K Kadel</last_name>
      <phone>+914023320338</phone>
      <email>jkishorek71@yahoo.co.in</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Care Hospitals</name>
      <address>
        <city>Hyderabad</city>
        <state>Andhra Pradesh</state>
        <zip>500034</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Raj Dudam</last_name>
      <phone>+914030418424</phone>
      <email>docterrajkiran@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Krishna Institute of Medical Sciences Ltd.</name>
      <address>
        <city>Secunderabad</city>
        <state>Andhra Pradesh</state>
        <zip>500003</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sarath C Veeravalli</last_name>
      <phone>+914044885074</phone>
      <email>sarath10@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yashoda Hospital</name>
      <address>
        <city>Secunderabad</city>
        <state>Andhra Predesh</state>
        <zip>500003</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Arindam N Roy</last_name>
      <phone>+914027809830</phone>
      <email>dr.arindam@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maulana Azad Medical College &amp; Associated Lok Nayak Hospitals</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110002</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Suresh Kumar</last_name>
      <phone>+911123232400</phone>
      <email>drkumar31@yahoo.co.in</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>lndraprastha Apollo Hospitals</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110076</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sundeep K Upadhyaya</last_name>
      <phone>+911126250732</phone>
      <email>sundeepupadhyaya@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shalby Hospitals</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <zip>380015</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Reena Sharma</last_name>
      <phone>+917937299455</phone>
      <email>reena141@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Government Medical College &amp; New Civil Hospital</name>
      <address>
        <city>Surat</city>
        <state>Gujarat</state>
        <zip>395001</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Krishnakant Bhatt</last_name>
      <phone>+912612244456</phone>
      <email>knbsurat@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chanre Rheumatology &amp; Immunology Center &amp; Research</name>
      <address>
        <city>Bangalore</city>
        <state>Karnataka</state>
        <zip>560079</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chandrashekara Srikantiah</last_name>
      <phone>+919845071151</phone>
      <email>chanrericr@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sushruta Multispeciality Hospital &amp; Research Centre Pvt. Ltd</name>
      <address>
        <city>Hubli</city>
        <state>Karnataka</state>
        <zip>5880021</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vikram M Haridas</last_name>
      <phone>+918362278001</phone>
      <email>haridasvikram@yahoo.co.in</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jagadguru Sri Shivarathreeshwara Hospital</name>
      <address>
        <city>Mysore</city>
        <state>Karnataka</state>
        <zip>570004</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ramaswamy Subramanian</last_name>
      <phone>+918212548356</phone>
      <email>subsan05@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kokilaben Dhirubhai Ambani Hospital &amp; Medical Research Institute</name>
      <address>
        <city>Mumbai</city>
        <state>Maharashtra</state>
        <zip>400053</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jyotsna Oak</last_name>
      <phone>+912232459951</phone>
      <email>jyotsnaoak@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jehangir Clinical Development Centre Pvt. Ltd.</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411001</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shrikant Y Wagh</last_name>
      <phone>+912026059318</phone>
      <email>sywagh@yahoo.co.in</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Deennath Mangeshkar Hospital and Research Centre</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411004</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vaijayanti Joshi</last_name>
      <phone>+912066023000</phone>
      <email>research@dmhospital.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oyster &amp; Pearl Hospital</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411005</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Aniruddha Tembe</last_name>
      <phone>+912030205050</phone>
      <email>dr.atembe@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>lnamdar Multispeciality Hospital</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411040</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ajit Nalawade</last_name>
      <phone>+912030502257</phone>
      <email>dr_ajitnalawade@yahoo.co.in</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dayanand Medical College &amp; Hosptial</name>
      <address>
        <city>Ludhiana</city>
        <state>Punjab</state>
        <zip>141001</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dinesh Jain</last_name>
      <phone>+911612303163</phone>
      <email>drjaindinesh@yahoo.co.in</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>S. R. Kalla Memorial Gastro &amp; General Hospital</name>
      <address>
        <city>Jaipur</city>
        <state>Rajasthan</state>
        <zip>302001</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jugal B Gupta</last_name>
      <phone>+911412700181</phone>
      <email>guptadrjb@rediffmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shri Nidaan Hospital &amp; Hope Fertility Centre</name>
      <address>
        <city>Jaipur</city>
        <state>Rajasthan</state>
        <zip>302006</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Avinash Agarwal</last_name>
      <phone>+911412356669</phone>
      <email>dravitrial@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Apollo Specialty Hosptials</name>
      <address>
        <city>Madurai</city>
        <state>Tamil Nadu</state>
        <zip>625020</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sudhakar Paul</last_name>
      <phone>+914522580894</phone>
      <email>scrcmdu@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>King George's Medical University</name>
      <address>
        <city>Lucknow</city>
        <state>Uttar Pradesh</state>
        <zip>226018</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Puneet Kumar</last_name>
      <phone>+915202614026</phone>
      <email>puneet_sarwan@rediffmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Communal Healthcare Institution Kharkiv City Clinical Hospital #8</name>
      <address>
        <city>Kharkiv</city>
        <zip>61176</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vira Tseluyko</last_name>
      <phone>+380577109881</phone>
      <email>tseluyko@inbox.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>State Institution National Scientific Center Acad. Strazhesko Institute of Cardiology of National Academy of Medical Science</name>
      <address>
        <city>Kyiv</city>
        <zip>03680</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olena Garmish</last_name>
      <phone>+380442756622</phone>
      <email>elena-garmish@yandex.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>State Institution D.F. Chebotariov Institute of Gerontology of NAMS of Ukraine</name>
      <address>
        <city>Kyiv</city>
        <zip>04114</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vladislav Povoroznyuk</last_name>
      <phone>+380444310550</phone>
      <email>ovioda_trial@ukr.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>M.V. Sklifosovskyi Poltava Regional Clinical Hospital</name>
      <address>
        <city>Poltava</city>
        <zip>36011</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vyacheslav Zhdan</last_name>
      <phone>+380532602051</phone>
      <email>ghdan@i.ua</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vinnytsia M.I. Pyrogov Regional Clinical Hospital</name>
      <address>
        <city>Vinnytsia</city>
        <zip>21018</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mykola Stanislavchuk</last_name>
      <phone>+380432570572</phone>
      <email>mstanislav53@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Clinical Investigational Center MC LLC Health Clinic</name>
      <address>
        <city>Vinnytsia</city>
        <zip>21029</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Oleksandr Golovchenko</last_name>
      <phone>+380432557866</phone>
      <email>alex_golovchenko@inbox.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Communal Institution Zaporzhzhia Regional Clinical Hospital of Zaporizhzhia Regional Council</name>
      <address>
        <city>Zaporizhzhia</city>
        <zip>69600</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dmytro Rekalov</last_name>
      <phone>+380612995438</phone>
      <email>direc@bigmir.net</email>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
    <country>Ukraine</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2014</study_first_submitted>
  <study_first_submitted_qc>November 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2014</study_first_posted>
  <last_update_submitted>November 18, 2014</last_update_submitted>
  <last_update_submitted_qc>November 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 20, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Rheumatoid arthritis</keyword>
  <keyword>Rituximab</keyword>
  <keyword>Pharmacokinetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rituximab</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

